Published in Clin Chim Acta on April 15, 1985
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ (2001) 2.74
Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr (1998) 2.41
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res (1995) 1.55
Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight. Ann Hum Genet (2000) 1.53
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J (2005) 1.53
Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem (1991) 1.42
Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem (1975) 1.39
An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum Genet (1990) 1.36
The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol (1991) 1.35
Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens (1998) 1.29
Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med (2001) 1.26
gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med (1998) 1.26
Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging (2000) 1.24
Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin Chem (1995) 1.24
Allele frequency distribution of the (TG)n(AG)m microsatellite in the apolipoprotein C-II gene. Genomics (1992) 1.20
Total bone and liver alkaline phosphatases in plasma: biological variations and reference limits. Clin Chem (1983) 1.16
UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol (1983) 1.14
Application of high-performance computing to numerical simulation of human movement. J Biomech Eng (1995) 1.11
Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem (1998) 1.11
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis (2000) 1.06
Need for revisiting the concept of reference values. Clin Chem Lab Med (2000) 1.04
Subcellular distribution of cytochrome P-450 in the brain. Brain Res (1986) 1.04
Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem (1993) 1.03
Wine, beer, and mortality in middle-aged men from eastern France. Arch Intern Med (1999) 1.03
Dietary intakes, eating style and overweight in the Stanislas Family Study. Int J Obes Relat Metab Disord (2000) 1.03
Human aminopeptidases: a review of the literature. J Clin Chem Clin Biochem (1988) 1.03
A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med (1998) 1.01
Drug metabolizing enzymes in the brain and cerebral microvessels. Brain Res Brain Res Rev (1991) 1.01
Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis (1992) 1.00
Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol (1993) 0.98
Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem (1994) 0.98
High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med (2000) 0.98
Genetics strongly determines the wall thickness of the left and right carotid arteries. Hum Genet (1998) 0.98
Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet (2001) 0.97
Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr (1994) 0.97
Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging (2001) 0.97
Expression of multiple gamma-glutamyltransferase genes in man. Biochem J (1994) 0.96
An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet (1989) 0.95
Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study. Gerontology (1990) 0.95
Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort. Int J Obes (Lond) (2010) 0.95
Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler Thromb Vasc Biol (1998) 0.94
Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study. Int J Obes (Lond) (2008) 0.94
Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin Chem (1998) 0.93
In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. J Pharmacol Exp Ther (1992) 0.92
Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake. Mol Psychiatry (2001) 0.92
Relations between reported alcohol consumption and certain biological variables in an "unselected" population. Clin Chem (1979) 0.92
Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study. Biochim Biophys Acta (2000) 0.91
Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels. Genet Epidemiol (1996) 0.91
Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett (1998) 0.90
ELISA of 6-beta-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy. Clin Chim Acta (1986) 0.90
The chemical modification of human liver UDP-glucuronosyltransferase UGT1*6 reveals the involvement of a carboxyl group in catalysis. FEBS Lett (1994) 0.89
An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism. Ann Biol Clin (Paris) (1986) 0.89
Comparison of cytochrome P-450 content and activities in liver microsomes of seven animal species, including man. Xenobiotica (1986) 0.89
Gamma-glutamyltransferase: nucleotide sequence of the human pancreatic cDNA. Evidence for a ubiquitous gamma-glutamyltransferase polypeptide in human tissues. Biochem Pharmacol (1992) 0.89
Genetic Polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation. Ann Hum Genet (2008) 0.88
Electrophoretic mobility, rosette formation and surface immunoglobulins of gradient fractionated human blood lymphocytes. Biomedicine (1974) 0.88
5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. Int J Obes Relat Metab Disord (2000) 0.88
Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Biochem J (1999) 0.88
Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J Lipid Res (1996) 0.88
Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones. Biochim Biophys Acta (1992) 0.88
Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures. Mol Pharmacol (1991) 0.87
Soluble transferrin receptor (sTfR): biological variations and reference limits. Clin Chem Lab Med (2001) 0.87
Genetic influences on lipid metabolism trait variability within the Stanislas Cohort. J Lipid Res (2001) 0.87
Frequencies of five genetic polymorphisms in coronarographed patients and effects on lipid levels in a supposedly healthy population. Clin Genet (1996) 0.86
Weights at birth and in early infancy, systolic pressure, and left ventricular structure in subjects aged 8 to 24 years. Hypertension (1996) 0.86
Total cholinesterase in plasma: biological variations and reference limits. Clin Chem (1985) 0.86
Biological variations in hyperlipidemic children and adolescents treated with fenofibrate. Clin Chim Acta (1981) 0.86
LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest (2001) 0.86
Laser immunonephelometry reference intervals for eight serum proteins in healthy children. Clin Chem (1992) 0.85
Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. J Neurol Sci (1997) 0.85
Albendazole sulfonation by rat liver cytochrome P-450c. J Pharmacol Exp Ther (1988) 0.85
A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol Pharmacol (1994) 0.85
Evidence for the pro-oxidant effect of gamma-glutamyltranspeptidase-related enzyme. Free Radic Biol Med (2000) 0.85
Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic Biol Med (2000) 0.85
The glucuronosyltransferases: what progress can pharmacologists expect from molecular biology and cellular enzymology? Biochem Pharmacol (1987) 0.85
A novel UDP-Glc-specific glucosyltransferase catalyzing the biosynthesis of 6-O-glucosides of bile acids in human liver microsomes. J Biol Chem (1993) 0.85
Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes. Arch Biochem Biophys (1990) 0.84
Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles. Genes Immun (2007) 0.84
Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease? Clin Chem (1996) 0.84
Induction of recombinant human gamma-glutamyl transferase by sodium butyrate in transfected V79 and CHO Chinese hamster cells. Biochem Biophys Res Commun (1993) 0.84
Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort. Pharmacogenomics J (2005) 0.84
A new aspect of the protective functions of the blood-brain barrier: activities of four drug-metabolizing enzymes in isolated rat brain microvessels. Life Sci (1988) 0.83
Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide. Mol Pharmacol (1995) 0.83
High sensitivity C-reactive protein (CRP) reference intervals in the elderly. Clin Chem Lab Med (2001) 0.83
Gamma-glutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals. Clin Chem (1977) 0.83
[Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies]. Ann Biol Clin (Paris) (2004) 0.83
Inducibility of rat brain drug-metabolizing enzymes. Eur J Drug Metab Pharmacokinet (1988) 0.83
[Viral theory of atherosclerosis. Role of cytomegalovirus]. Ann Biol Clin (Paris) (1993) 0.82
Expression and regulation of drug metabolizing enzymes in an immortalized rat hepatocyte cell line. Biochem Pharmacol (1991) 0.82
[Study of the determination of urea and citrulline in protein-containing media. Manual and automatic diacetylmonoxime method]. Clin Chim Acta (1968) 0.82
Electrophoretic mobility of gamma-glutamyltransferase in rat liver subcellular fractions. Evidence for structure difference from the kidney enzyme. Biochem J (1989) 0.82
Some kinetic properties of gamma-glutamyltransferase from rabbit liver. Biochim Biophys Acta (1981) 0.82
Comparative study of clofibric acid and bilirubin glucuronidation in human liver microsomes. Biochem Pharmacol (1987) 0.82
Kinetic properties of gamma-glutamyltransferase from human liver. Clin Chem (1980) 0.82
Phenobarbital induction of cytochrome P-450 and UDP-glucuronosyltransferase in rabbit liver plasma membranes. Enzyme (1982) 0.82
[Apolipoprotein E polymorphism in a Moroccan population: allele frequency and relation to plasma lipid concentrations]. Ann Biol Clin (Paris) (2002) 0.81
Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis (1998) 0.81
Glucuronidation of 2-arylpropionic acids pirprofen, flurbiprofen, and ibuprofen by liver microsomes. Drug Metab Dispos (1991) 0.81